<DOC>
	<DOCNO>NCT02035683</DOCNO>
	<brief_summary>The purpose study test whether early metabolic response , measure PET/CT scan first cycle chemotherapy , able predict patient advance NSCLC good prognosis .</brief_summary>
	<brief_title>PET/CT Scan Tool Rationalize Treatment Advanced NSCLC Patients Undergoing First Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Diagnosis cytologically histologically confirm nonsmall cell lung cancer . Metastatic ( stage IV , M1A M1B ) locally advanced ( stage IIIB , metastasis supraclavicular node ) accord TNM VII edition . Both patient first diagnosis disease recurrence initial surgery eligible . At least one target nontarget lesion accord RECIST revise version 1.1 . Age &gt; = 18 year . ECOG PS 02 . Life expectancy &gt; 3 month . Signed informed consent . Uncontrolled diabetes ( glucose &gt; 200 mg/dl EGFR mutation , patient test do . ( EGFR test require participation study , may conduct part normal clinical practice , patient EGFR mutation would candidate firstline chemotherapy . ) Any malignancy within 5 year ( except adequately treat carcinoma situ cervix basal squamous cell skin cancer surgically resect prostate cancer normal PSA ) . Pregnant lactating female . Previous medical therapy metastatic disease ( prior surgery , radiation therapy permit , well adjuvant medical therapy complete least 6 month prior study entry ) . Any poorly control illness ( include active infection , significant hepatic , renal , metabolic cardiac disease , myocardial infarction within previous 12 month ) may , accord physician 's judgement , interfere patient 's ability undergo chemotherapy and/or examination within study protocol Inability provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>metabolic response</keyword>
	<keyword>chemotherapy</keyword>
</DOC>